Corbus Pharmaceuticals Holdings (CRBP) Gains from Investment Securities (2013 - 2019)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Gains from Investment Securities came in at -$69821.0 in Q4 2019, down 303.65% year-on-year from $34284.0 in Q4 2018, and down 160.06% quarter-over-quarter from $116245.0 in Q3 2019.
Corbus Pharmaceuticals Holdings (CRBP) Gains from Investment Securities (2013 - 2019) Analysis & Trends
Corbus Pharmaceuticals Holdings' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$69821.0 for Q4 2019.
- On a quarterly basis, Gains from Investment Securities fell 303.65% year-over-year to -$69821.0 in Q4 2019; TTM through Dec 2019 was $45833.0, a 34.94% decrease from a year earlier, with the FY2019 full-year figure at $45833.0, down 34.94% from the prior year.
- Gains from Investment Securities fell to -$69821.0 in Q4 2019 per CRBP's latest filing, from $116245.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $116245.0 in Q3 2019 and bottomed at -$69821.0 in Q4 2019.
- The 4-year median for Gains from Investment Securities is $11983.5 (2017), against an average of $9731.4.
- Biggest YoY gain for Gains from Investment Securities was 2688.98% in 2019; the steepest drop was 303.65% in 2019.
- Year by year, Gains from Investment Securities stood at $26930.0 in 2015, then slumped by 278.17% to -$47982.0 in 2017, then soared by 171.45% to $34284.0 in 2018, then plunged by 303.65% to -$69821.0 in 2019.
- Per Business Quant, the three latest CRBP Gains from Investment Securities figures stand at -$69821.0 (Q4 2019), $116245.0 (Q3 2019), and -$13964.0 (Q2 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -69,821.00 |
| Dec 31, 2019 | -69,821.00 |
| Sep 30, 2019 | 116,245.00 |
| Sep 30, 2019 | 116,245.00 |
| Jun 30, 2019 | -13,964.00 |
| Jun 30, 2019 | -13,964.00 |
| Mar 31, 2019 | 13,373.00 |
| Mar 31, 2019 | 13,373.00 |
| Dec 31, 2018 | 34,284.00 |
| Dec 31, 2018 | 34,284.00 |
| Sep 30, 2018 | -4,490.00 |
| Sep 30, 2018 | -4,490.00 |
| Jun 30, 2018 | 31,409.00 |
| Jun 30, 2018 | 31,409.00 |
| Mar 31, 2018 | 9,245.00 |
| Mar 31, 2018 | 9,245.00 |
| Dec 31, 2017 | -47,982.00 |
| Dec 31, 2017 | -47,982.00 |
| Sep 30, 2017 | 14,633.00 |
| Sep 30, 2017 | 14,633.00 |